Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

5003 Background: Prostate cancer (PCa) incidence, mortality, and outcomes vary widely across race/ethnicity. The underlying drivers of these differences are multifactorial, including systemic barriers that lead to wide variation in access to care including genomic and precision medicine. Men of African ancestry (AFR) are particularly underrepresented in genomic and precision medicine studies....

  • Interesting article on who is getting genomic testing in prostate cancer and when in their treatment course they are getting it…Implications for treatment decisions!